Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response
  • Myriapod

KRAS/NRAS variants and copy number alterations prognostically stratify patients with sinonasal melanoma

  • Easy PGX, Myriapod

Jessica LucchettiAflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort

  • Myriapod, Myriapod NGS

Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort

  • Myriapod

Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World

  • Myriapod

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

  • Myriapod, Myriapod NGS

Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.

  • Easy PGX, Microsatelliti, Myriapod

Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma

  • Myriapod

Jonathan E Thompson, Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in veterinary medicine: Recent advances (2019-present).

  • Easy, Helix, Myriapod

EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience

  • Myriapod

Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis

Your next step starts here. Fill out the form and talk to us

Let's talk